Cost-effectiveness of lopinavir/ritonavir versus nelfinavir as the first-line highly active antiretroviral therapy regimen for HIV infection (Q44509935)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cost-effectiveness of lopinavir/ritonavir versus nelfinavir as the first-line highly active antiretroviral therapy regimen for HIV infection |
scientific article |
Statements
1 reference
Cost-effectiveness of lopinavir/ritonavir versus nelfinavir as the first-line highly active antiretroviral therapy regimen for HIV infection (English)
1 reference
Kit N Simpson
1 reference
Michelle P Luo
1 reference
Elinor Chumney
1 reference
Eugene Sun
1 reference
Scott Brun
1 reference
Talat Ashraf
1 reference
1 September 2004
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference